Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 2015

View Archived Issues

Researchers identify biomarkers for colorectal cancer blood test

Sangamo Biosciences to target BCL11A for beta-thalassemia and SCD

Lilly initiates phase III trial of anti-CGRP MAb in cluster headache

Phase I results for CV-9104

ValiRx updates on progress of ValiSeek's VAL-401

Phase I trial initiated for Emergent and GSK Ebola virus vaccine prime-boost regimen

DI-B4 monoclonal antibody well-tolerated in NHL and CLL patients

Initiation of a phase I/Ib trial of TG-1050

Agilis licenses Angelman syndrome gene therapy from University of South Florida

Sanofi licenses immunotherapeutic for celiac disease from Selecta Biosciences

Ono Pharmaceutical updates pipeline progress of fourth quarter of fiscal 2014

GlycoOptimization technology shows promising results for cancer therapy

Antabio receives funding to develop drugs for P. aeruginosa infection in CF patients

HA bioconjugates: intracellular drug delivery sistem with enhanced safety

FORUM develops Abeta production inhibitors

Novartis patents ERK2 inhibitors

Idenix disclose anti-HCV nucleotide prodrugs

BioCryst starts phase I trial of second-generation oral kallikrein inhibitor for HAE

Bayer presents compounds for bleeding disorders

TB Alliance initiates phase III trial of triple oral drug regimen in XDR-TB

Phase I trial initiated for Jiangsu Jindike Biotechnology influenza vaccine

PharmaMar's lurbinectedin enters phase III trial in ovarian, fallopian tube and peritoneal cancer

SYM-1219 enters phase III trial for bacterial vaginosis

AAV-Nrf2 rescues retinal function in AMD mouse model

Emergent BioSolutions to conduct process development for Soligenix's RiVax

Denali Therapeutics launched to develop neurodegenerative disease therapeutics

GlycoMimetics' GMI-1271 receives FDA orphan drug designation for AML

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...